ANI Pharmaceuticals launches Nitazoxanide Tablets, 500 mg.
ANI Pharmaceuticals (ANIP) announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide Tablets are the generic version of the ...
ANI Pharmaceuticals announces royalty obligation buyout for Iluvien, Yutiq
ANI Pharmaceuticals (ANIP) has completed the buyout of its 3.125% perpetual royalty obligation to SWK Funding on worldwide net revenues of ...
ANI Pharmaceuticals (NASDAQ:ANIP) Upgraded at StockNews.com
StockNews.com upgraded shares of ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) from a sell rating to a hold rating in a ...
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 28, 2025 ANI Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.63, expectations were $1.41. Operator: Good morning, everyone. Welcome to ...